Stockscreener 앱 받기
129.56
3.34%
4.19
시간 외 거래:
129.97
0.41
+0.32%
Merck Co Inc 주식(MRK)의 최신 뉴스
Merck & Co. focuses on long-term growth as a global healthcare leader - AD HOC NEWS
Merck to Hold Second-Quarter 2026 Sales and Earnings Conference Call Aug. 4 - Business Wire
Merck & Co earnings guidance frames 2026 outlook. Technicals show MRK trading in a tight range - AD HOC NEWS
Merck, AbbVie probed by US lawmakers over China clinical trials: report - Proactive financial news
Big Pharma Has a Case of Merger Mania - The Motley Fool
Merck & Co. dividend track and pharma pipeline, shares in a mature Dow component - AD HOC NEWS
Merck (NYSE:MRK) Draws Heat As Healthcare Surges - Kalkine Media
Merck & Co., Inc. Shs Unsponsored Brazilian Depository Receipt Repr 0.125 Sh - TradingView
Merck expands HIV drug access through state AIDS programs - Stock Titan
Merck Announces New Agreement with ADAP Crisis Task Force to Improve Access and Care for People Living with HIV - Business Wire
Merck & Company, Inc. (MRK) Stock Analysis: Evaluating Growth Prospects Amid a 1.35% Potential Upside - DirectorsTalk Interviews
Merck & Co. highlights Keytruda momentum, pharma stock in long-term focus - AD HOC NEWS
The Keytruda from Merck & Co. Inc.lung cancer data extend its reach - AD HOC NEWS
Merck & Co., Inc.(NYSE: MRK) added to Russell 1000 Dynamic Index - marketscreener.com
Levi & Korsinsky Notifies Merck & Co., Inc. Investors of a Class Action Lawsuit and Upcoming DeadlineMRK - The National Law Review
Merck & Co. updates on Keytruda data, shares anchored by strong oncology franchise - Ad-hoc-news.de
Merck & Co. opens the week with earnings focus, shares in New York - Ad-hoc-news.de
Lost Money on Merck & Co., Inc. (MRK)? Join Class Action Suit Seeking RecoveryContact Levi & Korsinsky - The National Law Review
Merck & Co., Inc. Actuals & Estimates (FWB:6MK) - TradingView
Merck & Co. highlights oncology pipeline, shares supported by long-term drug portfolio - Ad-hoc-news.de
Merck & Co, shares trade near Wall Street consensus - AD HOC NEWS
Merck & Co. Inc. stock underperforms Friday when compared to competitors despite daily gains - MarketWatch
Merck & Co., Inc. Actuals & Estimates (AQUISEU:6MKD) - TradingView
Merck & Co. sets Keytruda growth expectations, shares supported by oncology pipeline - AD HOC NEWS
Merck & Co., Inc. (MRK) is a trending stock: Facts to know before betting on it - MSN
Merck & Co. opens the week with analyst focus, shares on NYSE - AD HOC NEWS
Merck & Co., Inc. (MRK) Is a Trending Stock: Facts to Know Before Betting on It - Yahoo Finance
Qualcomm, Merck, Rockwell Automation: CNBC’s ‘Final Trades’Qualcomm (NASDAQ:QCOM), Simon Property Grou - Benzinga
Merck & Co. dividend track record, shares in focus on the NYSE - AD HOC NEWS
Cardano Risk Management B.V. Lowers Position in Merck & Co., Inc. $MRK - MarketBeat
Apella Capital LLC Has $4.42 Million Stake in Merck & Co., Inc. $MRK - MarketBeat
Top Merck & Co., Inc. (MRK) Competitors 2026 - MarketBeat
Merck & Co. lifts 2026 outlook, Keytruda and vaccines drive shares on Wall Street - Ad-hoc-news.de
Merck & Co., Inc. Actuals & Estimates (AQUISUK:6MKD) - TradingView
Enterprise value to revenue forward of Merck & Co., Inc. – HAN:6MK - TradingView
Merck & Co. updates pipeline and oncology focus, shares stay in the S&P 500 spotlight - AD HOC NEWS
Merck & Co., Inc. (NYSE:MRK) Sets New 12-Month HighTime to Buy? - MarketBeat
Merck & Co Inc Stock (MRK) Moved Up by 4.04% on Jun 25: A Full Analysis - TradingKey
Gilead's Trodelvy Expands Reach With New FDA Approval In Breast Cancer - Benzinga
Merck & Co., Inc. Actuals & Estimates (NYSE:MRK) - TradingView
MRK Forecast — Price Target — Prediction for 2027 - TradingView
Price to sales forward of Merck & Co., Inc. – HAN:6MK - TradingView
Merck & Co. updates late-stage cancer pipeline, shares on NYSE radar - Ad-hoc-news.de
Merck & Co., Inc. (MRK) Short Interest & Short Float | Updated Jun 2026 $MRK - MarketBeat
Merck (MRK) Stock Gets New Outperform Rating from CICC - Insider Monkey
Merck & Co., Inc. (NYSE:MRK) Now Covered by CICC Research - MarketBeat
Is Merck & Co., Inc. (MRK) Strengthening Its Vaccine Portfolio With New Capvaxive Approval? - Insider Monkey
Thrivent Large Cap Value Portfolio's Merck & Co Inc(MRK) Holding History - GuruFocus
CICC Initiates Merck & Co. at Outperform With $138 Price Target - marketscreener.com
THRIVENT HEALTHCARE PORTFOLIO's Merck & Co Inc(MRK) Holding History - GuruFocus
Merck & Co. clears a short-term technical mark, shares extend their recent advance - Ad-hoc-news.de
Is Merck & Co Inc (MRK) Overvalued After 3.6% Rally? GF Value Sa - GuruFocus
Merck & Co Inc Stock (MRK) Moved Up by 3.23% on Jun 23: Key Drivers Unveiled - TradingKey
Merck's Anti-TL1A Antibody Meets Goal in Ulcerative Colitis Study - Yahoo Finance Singapore
Merck & Co. Inc. stock outperforms competitors on strong trading day - MarketWatch
Merck & Co. outlines strategic pipeline moves, shares hold steady on NYSE - AD HOC NEWS
Merck Scores Key Phase 3 Win For Novel Ulcerative Colitis Therapy - Benzinga
Merck’s Oncology Engine Is Still Accelerating (NYSE:MRK) - Seeking Alpha
Merck & Co. eyes oncology and vaccine strategy, shares tracked against big pharma peers - AD HOC NEWS
Merck’s Tulisokibart Met Primary and Key Secondary Endpoints in the Phase 3 ATLAS-UC Induction-only Study in Patients With Moderately to Severely Active Ulcerative Colitis (UC) - Business Wire
Berenberg Adjusts Price Target on Merck & Co. to $125 From $115, Maintains Hold Rating - marketscreener.com
Why Merck (MRK) Is Using KEYTRUDA and WELIREG to Deepen Its Kidney Cancer Franchise - Insider Monkey
Merck & Co. Stockweekly review and pharma peer comparison - AD HOC NEWS
Penn Series Large Core Value Fund's Merck & Co Inc(MRK) Holding History - GuruFocus
symbol__ Stock Quote Price and Forecast - CNN
LVIP MFS Value Fund's Merck & Co Inc(MRK) Holding History - GuruFocus
Is Merck's Recent Restructuring a Confident Pivot or a Defensive Maneuver - Kavout | AI
Merck & Co., Inc. Sued for Securities Law ViolationsInvestors - The National Law Review
Merck & Co. Inc. stock outperforms competitors despite losses on the day - MarketWatch
FDA Expands Merck Pneumococcal Shot Label To Include At-Risk Children And Teens - Benzinga
3.74%
자본화:
|
볼륨(24시간):